<?xml version="1.0" encoding="UTF-8"?>
 <rdf:RDF xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:cc="http://web.resource.org/cc/" xmlns:syn="http://purl.org/rss/1.0/modules/syndication/" xmlns:admin="http://webns.net/mvcb/">
  <channel rdf:about="http://pinboard.in">
    <title>Pinboard (Michael.Massing)</title>
    <link>https://pinboard.in/u:Michael.Massing/public/</link>
    <description>recent bookmarks from Michael.Massing</description>
    <items>
      <rdf:Seq>	<rdf:li rdf:resource="https://www.history.com/news/chamberlain-kahn-act-std-venereal-disease-imprisonment-women"/>
	<rdf:li rdf:resource="https://www.medpagetoday.com/publichealthpolicy/generalprofessionalissues/87008?xid=nl_mpt_DHE_2020-06-12&amp;eun=g894600d0r"/>
	<rdf:li rdf:resource="https://tobaccocontrol.bmj.com/content/27/Suppl_1/s7"/>
	<rdf:li rdf:resource="https://tobacco.ucsf.edu/pmi-using-fda-sell-iqos-outside-us"/>
	<rdf:li rdf:resource="https://www.pmi.com/resources/docs/default-source/pmi-innovation/scientific-update-issue-5-june-2018.pdf?sfvrsn=8bfe99b5_4"/>
	<rdf:li rdf:resource="https://www.fda.gov/tobacco-products/advertising-and-promotion/modified-risk-tobacco-products#Resources"/>
	<rdf:li rdf:resource="https://www.cdc.gov/statesystem/preemption.html"/>
	<rdf:li rdf:resource="https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm618883.htm"/>
	<rdf:li rdf:resource="http://www.nytimes.com/2013/06/09/opinion/sunday/dont-take-your-vitamins.html"/>
	<rdf:li rdf:resource="https://www.nytimes.com/2015/02/06/opinion/the-politics-of-fraudulent-dietary-supplements.html?_r=0"/>
	<rdf:li rdf:resource="http://www.ncbi.nlm.nih.gov/pubmed/2905942"/>
	<rdf:li rdf:resource="http://rainnews.com/live365-suffers-a-collision-of-misfortune-lays-off-most-employees-and-vacates-office/"/>
	<rdf:li rdf:resource="http://www.sciencedaily.com/releases/2010/06/100608182645.htm"/>
	<rdf:li rdf:resource="http://ajpendo.physiology.org/content/306/5/E552.long"/>
	<rdf:li rdf:resource="http://www.theguardian.com/commentisfree/2014/dec/03/im-no-fan-of-the-porno-industrial-complex-but-these-new-rules-are-unworkable?CMP=twt_gu"/>
	<rdf:li rdf:resource="http://blog.wegohealth.com/2013/05/01/guest-post-yoga-supports-self-regulation-and-sensory-processing/"/>
	<rdf:li rdf:resource="http://www.economist.com/blogs/freeexchange/2013/03/utilities"/>
	<rdf:li rdf:resource="http://www.alternet.org/newsandviews/article/933481/gun_deaths_outpace_motor_vehicle_deaths_in_10_states/"/>
	<rdf:li rdf:resource="http://www.thedailybeast.com/articles/2011/01/11/20-deadliest-gun-states-from-mississippi-to-arizona.html"/>
	<rdf:li rdf:resource="http://www.sfgate.com/technology/dotcommentary/article/Web-Privacy-Census-shows-tracking-pervasive-3663642.php"/>
	<rdf:li rdf:resource="http://www.scientificamerican.com/article.cfm?id=epa-atrazine-herbicide"/>
	<rdf:li rdf:resource="http://www.diabetesincontrol.com/index.php?option=com_content&amp;task=view&amp;id=12007&amp;Itemid=8"/>
	<rdf:li rdf:resource="http://www.cnet.com/8301-17918_1-57367751-85/hey-at-t-quit-whining/?tag=rtcol"/>
	<rdf:li rdf:resource="http://www.diabetesincontrol.com/articles/53-diabetes-news/9249-iom-recommends-fda-set-new-standards-for-salt-in-foods"/>
	<rdf:li rdf:resource="http://www.guardian.co.uk/commentisfree/2011/may/07/ben-goldacre-bad-science-new-drugs"/>
	<rdf:li rdf:resource="http://www.badscience.net/2010/07/i-love-research-about-research/#more-1738"/>
	<rdf:li rdf:resource="http://www.badscience.net/2009/12/by-me-in-the-bmj-the-dodginess-of-drug-company-trials/#more-1408"/>
	<rdf:li rdf:resource="http://www.badscience.net/2010/07/pharmaco-epidemiology-would-be-fascinating-enough-even-if-society-didnt-manage-it-really-really-badly/#more-1723"/>
	<rdf:li rdf:resource="http://www.nytimes.com/2011/02/08/us/politics/08obama-text.html?pagewanted=all"/>
	<rdf:li rdf:resource="http://www.hpj.com/archives/2011/apr11/apr18/0401PreventFoodborneIllness.cfm?title=Health%20pros%20identify%20top%2010%20culprits%20in%20foodborne%20illnesses"/>
	<rdf:li rdf:resource="http://docs.google.com/viewer?a=v&amp;q=cache:uEsbgLFRoc8J:www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm071627.pdf+cardiovascular+treatment+type+2&amp;hl=en&amp;gl=us&amp;pid=bl&amp;srcid=ADGEESi3fTuyDxtLulfV739fcXV7-uTeJVUGenVFhIg5V-mbUx3uCYVFtTdgupdpJe4n3kT3mCpoTfIzZTgMQYvbJKhF5UyISC-QmK2yjHyrXqXJV9FpObKUjvROJRcnUeZo1-mgaxI4&amp;sig=AHIEtbT_0VRvaXr86ZmE0PXg8ihqP2Vo1g"/>
	<rdf:li rdf:resource="http://en.wikipedia.org/wiki/Bates_method#Margaret_Darst_Corbett"/>
	<rdf:li rdf:resource="http://www.miller-mccune.com/politics/are-more-gun-laws-for-mentally-ill-off-target-26967/"/>
	<rdf:li rdf:resource="http://www.scienceline.org/2010/12/drugs-and-social-media-don%E2%80%99t-mix/"/>
	<rdf:li rdf:resource="http://www.dlife.com/diabetes-news/2009/10/common_herbicides_and_fibrate.html"/>
      </rdf:Seq>
    </items>
  </channel><item rdf:about="https://www.history.com/news/chamberlain-kahn-act-std-venereal-disease-imprisonment-women">
    <title>America's Forgotten Mass Imprisonment of Women Believed to Be Sexually Immoral - HISTORY</title>
    <dc:date>2022-04-09T01:41:16+00:00</dc:date>
    <link>https://www.history.com/news/chamberlain-kahn-act-std-venereal-disease-imprisonment-women</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[The American Plan began during World War I, as the result of a federal push to prevent soldiers and sailors from contracting STIs. In 1917, federal officials were horrified to learn that a huge percentage of men in the military (some erroneously estimated one in three) were infected with syphilis or gonorrhea. Suddenly these diseases presented not just a health threat—but a national security threat as well. So officials passed a federal law that outlawed sex work within a five-mile “moral zone” of every military training camp in the country. When they learned that most infected soldiers and sailors actually contracted their STIs back in their hometowns, they worked to expand this prohibition to cover the entire nation. And when they discovered that most of the women who supposedly infected the men weren’t professional prostitutes, they expanded the program even further.

So, beginning in 1918, federal officials began pushing every state in the nation to pass a “model law,” which enabled officials to forcibly examine any person “reasonably suspected” of having an STI. Under this statute, those who tested positive for an STI could be held in detention for as long as it took to render him or her noninfectious. (On paper, the law was gender-neutral; in practice, it almost exclusively focused on regulating women and their bodies.)

The Plan enjoyed complicity, if not outright support, in high places. New York Mayor Fiorello La Guardia gave speeches lauding the Plan; then-California Governor Earl Warren personally spearheaded its enforcement in his state. In 1918, the attorney general personally sent a letter to every U.S. attorney in the country, assuring them this law was constitutional; he also sent a letter to every U.S. district judge, urging them not to interfere with its enforcement. During World War II, the American Civil Liberties Union not only failed to oppose the Plan; its founder, Roger Baldwin, sent a memorandum encouraging its local branches to cooperate with officials enforcing it.]]></description>
<dc:subject>morals charges detention women due process STI sexually transmitted infection disease regulation women's bodies carceral state</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:34009fd6ce4f/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:morals"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:charges"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:detention"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:women"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:due"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:process"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:STI"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:sexually"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:transmitted"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:infection"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:disease"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:regulation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:women's"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:bodies"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:carceral"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:state"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.medpagetoday.com/publichealthpolicy/generalprofessionalissues/87008?xid=nl_mpt_DHE_2020-06-12&amp;eun=g894600d0r">
    <title>What Police Chokeholds Can Do to the Brain | MedPage Today</title>
    <dc:date>2020-10-29T22:56:49+00:00</dc:date>
    <link>https://www.medpagetoday.com/publichealthpolicy/generalprofessionalissues/87008?xid=nl_mpt_DHE_2020-06-12&amp;eun=g894600d0r</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>chokehold police tactics restraint regulation ban prohibition brain physical damage carotid injury oversight</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:4d28b84423b2/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:chokehold"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:police"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:tactics"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:restraint"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:regulation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:ban"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:prohibition"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:brain"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:physical"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:damage"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:carotid"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:injury"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:oversight"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://tobaccocontrol.bmj.com/content/27/Suppl_1/s7">
    <title>Heated tobacco products: things we do and do not know | Tobacco Control</title>
    <dc:date>2020-01-11T18:28:31+00:00</dc:date>
    <link>https://tobaccocontrol.bmj.com/content/27/Suppl_1/s7</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[Most in the public health world would agree that the best evidence-based approaches should be applied to reduce death and illness due to tobacco use. Such approaches may include supporting addicted tobacco users to move to alternatives that are less harmful and truly reduce the population burden of tobacco diseases. It is important to bear in mind these two goals – alternative tobacco delivery devices may be less risky than combustible cigarettes for the individual smoker, but if they do not lead to a reduction in the prevalence of smoking there is no gain for public health.

What do we know about the safety of IQOS and the effect that introduction of these devices may have on smoking rates and the population burden of disease and premature mortality? Unfortunately information about IQOS and similar products is, at present, largely limited to industry reports. These include observations from marketing and data from product toxicity and human exposure studies. The papers in this Special Issue take a close look at the industry material, as well as the limited emerging academic literature on HTPs. The findings in broad terms are not terribly surprising. Data are scarce, and in particular, there are no long-term studies in human populations of the consequences of use of IQOS. Nevertheless an addictive product is being promoted by over-emphasising (or in some cases exaggerating) the limited evidence for its capacity to reduce harm, while minimising evidence on its potential toxicity. A sceptical view, conditioned by history, would be that this may be part of strategic efforts by the industry to retain existing consumers of tobacco products and generate new lifelong nicotine-dependent users. We offer some suggestions about what we do not know at present about IQOS, but need to understand to best inform tobacco control policies.]]></description>
<dc:subject>HTP tobacco public health risk regulation product development approval international marketing addiction</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:66d6e4241668/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:HTP"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:tobacco"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:public"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:health"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:risk"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:regulation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:product"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:development"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:approval"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:international"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:marketing"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:addiction"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://tobacco.ucsf.edu/pmi-using-fda-sell-iqos-outside-us">
    <title>PMI is using the FDA to sell IQOS outside the US | Center for Tobacco Control Research and Education</title>
    <dc:date>2020-01-11T14:19:28+00:00</dc:date>
    <link>https://tobacco.ucsf.edu/pmi-using-fda-sell-iqos-outside-us</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>PMI HTP tobacco public health FDA risk regulation product development approval international marketing authorization</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:0199fb8fcad4/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:PMI"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:HTP"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:tobacco"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:public"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:health"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:FDA"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:risk"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:regulation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:product"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:development"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:approval"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:international"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:marketing"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:authorization"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.pmi.com/resources/docs/default-source/pmi-innovation/scientific-update-issue-5-june-2018.pdf?sfvrsn=8bfe99b5_4">
    <title>[untitled]</title>
    <dc:date>2020-01-11T13:53:05+00:00</dc:date>
    <link>https://www.pmi.com/resources/docs/default-source/pmi-innovation/scientific-update-issue-5-june-2018.pdf?sfvrsn=8bfe99b5_4</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>HTP tobacco public health FDA risk regulation product development PMI approval</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:01c734c540db/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:HTP"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:tobacco"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:public"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:health"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:FDA"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:risk"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:regulation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:product"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:development"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:PMI"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:approval"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.fda.gov/tobacco-products/advertising-and-promotion/modified-risk-tobacco-products#Resources">
    <title>Modified Risk Tobacco Products | FDA</title>
    <dc:date>2020-01-10T15:23:54+00:00</dc:date>
    <link>https://www.fda.gov/tobacco-products/advertising-and-promotion/modified-risk-tobacco-products#Resources</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>smoking MRTP modified risk reduced US regulation FDA tobacco strategy products</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:9bf6ad45c3cd/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:smoking"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:MRTP"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:modified"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:risk"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:reduced"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:US"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:regulation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:FDA"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:tobacco"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:strategy"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:products"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.cdc.gov/statesystem/preemption.html">
    <title>Map of Preemption on Advertising, Licensure, Smokefree Indoor Air, and Youth Access | STATE System | CDC</title>
    <dc:date>2020-01-07T14:18:29+00:00</dc:date>
    <link>https://www.cdc.gov/statesystem/preemption.html</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[State Tobacco Activities Tracking and Evaluation (STATE) System]]></description>
<dc:subject>smoking economics demographics national statistics data tobacco strategy prevention mitigation public health CDC regulation restriction</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:e512db974ec1/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:smoking"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:economics"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:demographics"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:national"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:statistics"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:data"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:tobacco"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:strategy"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:prevention"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:mitigation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:public"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:health"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:CDC"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:regulation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:restriction"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm618883.htm">
    <title>Press Announcements &gt; Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s support for exempting coffee from California’s cancer warning law</title>
    <dc:date>2018-08-30T17:22:05+00:00</dc:date>
    <link>https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm618883.htm</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[if a state law purports to require food labeling to include a false or misleading statement, the FDA may decide to step in.

That’s why we were deeply concerned when a court recently ruled that a California law – known as Proposition 65 – may require coffee sold in California to be labeled with a cancer warning because of the presence of a chemical called acrylamide. Under Proposition 65, California requires that certain products contain cancer warnings if they will expose consumers to chemicals that California health authorities have identified as causing cancer. But requiring a cancer warning on coffee, based on the presence of acrylamide, would be more likely to mislead consumers than to inform them.]]></description>
<dc:subject>coffee risk benefit FDA state regulation California</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:726658567bb4/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:coffee"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:risk"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:benefit"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:FDA"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:state"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:regulation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:California"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.nytimes.com/2013/06/09/opinion/sunday/dont-take-your-vitamins.html">
    <title>Don’t Take Your Vitamins - The New York Times</title>
    <dc:date>2017-07-18T21:39:55+00:00</dc:date>
    <link>http://www.nytimes.com/2013/06/09/opinion/sunday/dont-take-your-vitamins.html</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[In December 1972, concerned that people were consuming larger and larger quantities of vitamins, the F.D.A. announced a plan to regulate vitamin supplements containing more than 150 percent of the recommended daily allowance. Vitamin makers would now have to prove that these “megavitamins” were safe before selling them. Not surprisingly, the vitamin industry saw this as a threat, and set out to destroy the bill. In the end, it did far more than that.

Industry executives recruited William Proxmire, a Democratic senator from Wisconsin, to introduce a bill preventing the F.D.A. from regulating megavitamins. On Aug. 14, 1974, the hearing began.

Speaking in support of F.D.A. regulation was Marsha Cohen, a lawyer with the Consumers Union. Setting eight cantaloupes in front of her, she said, “You would need to eat eight cantaloupes — a good source of vitamin C — to take in barely 1,000 milligrams of vitamin C. But just these two little pills, easy to swallow, contain the same amount.” She warned that if the legislation passed, “one tablet would contain as much vitamin C as all of these cantaloupes, or even twice, thrice or 20 times that amount. And there would be no protective satiety level.” Ms. Cohen was pointing out the industry’s Achilles’ heel: ingesting large quantities of vitamins is unnatural, the opposite of what manufacturers were promoting.

A little more than a month later, Mr. Proxmire’s bill passed by a vote of 81 to 10. In 1976, it became law. Decades later, Peter Barton Hutt, chief counsel to the F.D.A., wrote that “it was the most humiliating defeat” in the agency’s history.

As a result, consumers don’t know that taking megavitamins could increase their risk of cancer and heart disease and shorten their lives; they don’t know that they have been suffering too much of a good thing for too long.

]]></description>
<dc:subject>history vitamin supplements risk legislation regulation FDA lobbying industry capital benefit</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:b108fe956082/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:history"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:vitamin"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:supplements"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:risk"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:legislation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:regulation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:FDA"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:lobbying"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:industry"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:capital"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:benefit"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="https://www.nytimes.com/2015/02/06/opinion/the-politics-of-fraudulent-dietary-supplements.html?_r=0">
    <title>The Politics of Fraudulent Dietary Supplements - The New York Times</title>
    <dc:date>2017-02-08T16:21:21+00:00</dc:date>
    <link>https://www.nytimes.com/2015/02/06/opinion/the-politics-of-fraudulent-dietary-supplements.html?_r=0</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>Orrin Hatch nutritional supplements regulation disclosure fraud waste self care healthcare health politics self-dealing right wing</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:a4a1ece0e0b0/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Orrin"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Hatch"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:nutritional"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:supplements"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:regulation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:disclosure"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:fraud"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:waste"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:self"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:care"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:healthcare"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:health"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:politics"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:self-dealing"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:right"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:wing"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.ncbi.nlm.nih.gov/pubmed/2905942">
    <title>Marked impairment of the effect of hyperglycaemia on glucose uptake and glucose production in insulin-dependent diabetes. - PubMed - NCBI</title>
    <dc:date>2016-01-10T04:37:21+00:00</dc:date>
    <link>http://www.ncbi.nlm.nih.gov/pubmed/2905942</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[whereas in control subjects glucose production was suppressed during hyperglycaemia of 16.7 mmol l-1 (0.3 +/- 0.4 mg kg-1 min-1, p less than 0.01), a slight increase was observed in diabetic patients (2.0 +/- 0.2 mg kg-1 min-1, p less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)
]]></description>
<dc:subject>glucose metabolism hepatic production hyperglycemia peer-reviewed research liver regulation insulin-dependent normoglycemia</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:5cccdc9f76bc/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:glucose"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:metabolism"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:hepatic"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:production"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:hyperglycemia"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:peer-reviewed"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:liver"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:regulation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:insulin-dependent"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:normoglycemia"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://rainnews.com/live365-suffers-a-collision-of-misfortune-lays-off-most-employees-and-vacates-office/">
    <title>Live365 suffers a collision of misfortunes, lays off most employees and vacates office – RAIN News</title>
    <dc:date>2016-01-03T18:23:15+00:00</dc:date>
    <link>http://rainnews.com/live365-suffers-a-collision-of-misfortune-lays-off-most-employees-and-vacates-office/</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[RT @MaureenSRN Live365 suffers a collision of misfortunes, lays off most employees and vacates office – RAIN News ]]></description>
<dc:subject>broadcast regulation economics finance oligopoly distribution royalties radio Internet web webcasting</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:5d5b71128f78/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:broadcast"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:regulation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:economics"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:finance"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:oligopoly"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:distribution"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:royalties"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:radio"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Internet"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:web"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:webcasting"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.sciencedaily.com/releases/2010/06/100608182645.htm">
    <title>Molecular link between diabetes and schizophrenia connects food and mood -- ScienceDaily</title>
    <dc:date>2015-10-20T15:17:27+00:00</dc:date>
    <link>http://www.sciencedaily.com/releases/2010/06/100608182645.htm</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[Galli's group was among the first to show that insulin -- the hormone that governs glucose metabolism in the body -- also regulates the brain's supply of dopamine -- a neurotransmitter with roles in motor activity, attention and reward. Disrupted dopamine signaling has been implicated in brain disorders including depression, Parkinson's disease, schizophrenia and attention-deficit hyperactivity disorder.

Now, Galli, Niswender, and colleagues have pieced together the molecular pathway between perturbed insulin signaling in the brain and dopamine dysfunction leading to schizophrenia-like behaviors....

They also showed how defects in insulin signaling disrupt neurotransmitter levels in the brain -- the mice have reduced dopamine and elevated norepinephrine in the prefrontal cortex, an important area for cognitive processes. These changes resulted from elevated levels of the transporter protein (NET) that removes norepinephrine and dopamine from the synaptic space between neurons.

"We believe the excess NET is sucking away all of the dopamine and converting it to norepinephrine, creating this situation of hypodopaminergia (low levels of dopamine) in the cortex," Galli explained. Low dopamine function in the cortex is thought to contribute to the cognitive deficits and negative symptoms -- depression, social withdrawal -- associated with schizophrenia.]]></description>
<dc:subject>diabetes correlation schizophrenia insulin neurotransmitter endocrine molecular diseaseome link genetics etiology neuroendocrine cause causation in vivo animal peer-reviewed research dopamine regulation psychotropic attention reward norepinephrine depression cognition food foods risk factor genetic</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:9bc39a261f93/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:correlation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:schizophrenia"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:insulin"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:neurotransmitter"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:endocrine"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:molecular"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diseaseome"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:link"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:genetics"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:etiology"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:neuroendocrine"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cause"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:causation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:in"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:vivo"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:animal"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:peer-reviewed"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:dopamine"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:regulation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:psychotropic"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:attention"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:reward"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:norepinephrine"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:depression"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cognition"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:food"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:foods"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:risk"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:factor"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:genetic"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://ajpendo.physiology.org/content/306/5/E552.long">
    <title>Long-term ketogenic diet causes glucose intolerance and reduced β- and α-cell mass but no weight loss in mice | Endocrinology and Metabolism</title>
    <dc:date>2015-08-15T20:42:02+00:00</dc:date>
    <link>http://ajpendo.physiology.org/content/306/5/E552.long</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[High-fat, low-carbohydrate ketogenic diets (KD) are used for weight loss[, short-term glucose regulation in the obese and effective] treatment of refractory epilepsy. Recently, short-time studies in rodents have shown that, besides their beneficial effect on body weight, KD lead to glucose intolerance and insulin resistance....In this study...[d]espite an initial weight loss, KD did not result in weight loss after 22 wk....Our data show that long-term KD causes dyslipidemia, a proinflammatory state, signs of hepatic steatosis, glucose intolerance, and a reduction in β- and α-cell mass, but no weight loss. This indicates that long-term high-fat, low-carbohydrate KD lead to features that are also associated with the metabolic syndrome and an increased risk for type 2 diabetes in humans.]]></description>
<dc:subject>low-carb high-fat low-carbohydrate ketogenic diet long-term correlation glucose intolerance and reduced β- α-cell mass but no weight loss in vivo animal dyslipidemia pro-inflammatory hepatic steatosis fatty liver beta cells pancreas metabolic syndrome peer-reviewed research risk type 2 diabetes T2D control maintenance benefit epilepsy regulation management</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:b2c0f8ff3859/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:low-carb"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:high-fat"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:low-carbohydrate"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:ketogenic"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diet"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:long-term"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:correlation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:glucose"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:intolerance"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:and"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:reduced"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:β-"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:α-cell"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:mass"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:but"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:no"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:weight"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:loss"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:in"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:vivo"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:animal"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:dyslipidemia"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:pro-inflammatory"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:hepatic"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:steatosis"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:fatty"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:liver"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:beta"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cells"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:pancreas"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:metabolic"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:syndrome"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:peer-reviewed"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:risk"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:2"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T2D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:control"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:maintenance"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:benefit"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:epilepsy"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:regulation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:management"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.theguardian.com/commentisfree/2014/dec/03/im-no-fan-of-the-porno-industrial-complex-but-these-new-rules-are-unworkable?CMP=twt_gu">
    <title>I’m no fan of the porno-industrial complex but these new rules are unworkable | Suzanne Moore | Comment is free | The Guardian</title>
    <dc:date>2014-12-25T14:25:09+00:00</dc:date>
    <link>http://www.theguardian.com/commentisfree/2014/dec/03/im-no-fan-of-the-porno-industrial-complex-but-these-new-rules-are-unworkable?CMP=twt_gu</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>porn feminism censorship speech regulation legislation UK criticism theory pornography</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:1eb10a5f0bae/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:porn"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:feminism"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:censorship"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:speech"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:regulation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:legislation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:UK"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:criticism"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:theory"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:pornography"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://blog.wegohealth.com/2013/05/01/guest-post-yoga-supports-self-regulation-and-sensory-processing/">
    <title>Guest Post: Yoga Supports Self-Regulation and Sensory Processing</title>
    <dc:date>2013-05-04T20:42:26+00:00</dc:date>
    <link>http://blog.wegohealth.com/2013/05/01/guest-post-yoga-supports-self-regulation-and-sensory-processing/</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[Weight bearing poses that give strong feedback to muscles and joints, and deep-pressure provide proprioceptive input, which increases body awareness and is grounding and organizing. Movements such as bouncing, jumping up and down, and rocking back and forth provide linear vestibular input, which tends to be organizing. Activities that involve spinning, rolling and turning the body upside down provide vestibular input that tends to be alerting and arousing. The same vestibular input can have a calming or exciting effect, depending on the child and the circumstance. You can rarely overdo proprioceptive input but you can overdo vestibular input. Olfactory and auditory inputs can be used to regulate arousal levels as well. The most beneficial regulatory tools we can provide children are those they can incorporate independently in discrete and socially appropriate ways. Connections can be made during yoga class between specific movements and activities and their impact on one’s arousal level to help children better understand their own nervous systems. Many children need to move and take in sensory-motor input in order to pay attention. We need to be sensory detectives to determine what kind of movement or sensory-input a child is craving so we can provide them with what they need and ideally teach them to provide it to themselves.]]></description>
<dc:subject>yoga self care child development behavior regulation nervous system children</dc:subject>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:077931acf623/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:yoga"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:self"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:care"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:child"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:development"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:behavior"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:regulation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:nervous"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:system"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:children"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.economist.com/blogs/freeexchange/2013/03/utilities">
    <title>Utilities: Google's Google problem | The Economist</title>
    <dc:date>2013-03-23T21:53:49+00:00</dc:date>
    <link>http://www.economist.com/blogs/freeexchange/2013/03/utilities</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[The more we all participate in this world [of instantly and universally available information], the more we come to depend on it. The more it becomes the world.

What Google has actually done is create a powerful infrastructure. The shape of that infrastructure influences everything that goes online. And it influences the allocation of mental resources of everyone who interacts with the online world....

That's a lot of power to put in the hands of a company that now seems interested, mostly, in identifying core mass-market services it can use to maximise its return on investment. Now in the short run, that may mostly be a problem for all of us. To the extent that we become worried about this phenomenon, we may go out and find back-up services or other alternatives. This will be less convenient and more costly, in terms of time and money, but those sufficiently foresighted might feel it's a better option than opening up gmail one day to read that the email service, and the 10-year's worth of communication it holds, will soon be gone.

But in the long run that's a problem for Google. Because we tend not to entrust this sort of critical public infrastructure to the private sector. Network externalities are all fine and good to ignore so long as they mainly apply to the sharing of news and pics from a weekend trip with college friends. Once they concern large swathes of economic output and the cognitive activity of millions of people, it is difficult to keep the government out. Maybe that deterrent will be sufficient to keep Google providing its most heavily used products. But maybe not.

I find myself thinking again of the brave new world of the industrial city, when new patterns of interaction led to enormous changes in economic activity, in culture and personal behaviour, and in the way we think. We upgraded ourselves, in terms of education, hygiene, and social norms, to maximise the return to urban life. And the history of modern urbanisation is littered with examples of privately provided goods and services that became the domain of the government once everyone realised that this new life and new us couldn't work without them.]]></description>
<dc:subject>public utilities interst trust government governance infrastructure Economist intervention subvention regulation history Industrial Revolution urbanization UK US social criticism capitalism organization Google</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:9b5535caac86/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:public"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:utilities"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:interst"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:trust"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:government"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:governance"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:infrastructure"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Economist"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:intervention"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:subvention"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:regulation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:history"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Industrial"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Revolution"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:urbanization"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:UK"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:US"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:social"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:criticism"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:capitalism"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:organization"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Google"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.alternet.org/newsandviews/article/933481/gun_deaths_outpace_motor_vehicle_deaths_in_10_states/">
    <title>Gun Deaths Outpace Motor Vehicle Deaths in 10 States | Alternet</title>
    <dc:date>2012-08-08T08:18:20+00:00</dc:date>
    <link>http://www.alternet.org/newsandviews/article/933481/gun_deaths_outpace_motor_vehicle_deaths_in_10_states/</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[ 
 
 

According to the Violence Policy Center’s (VPC) new state-by-state analysis of the latest 2009 government data, gun-related deaths outpaced motor vehicle deaths in 10 states.  The 10 states are: Alaska, Arizona, Colorado, Indiana, Michigan, Nevada, Oregon, Utah, Virginia, and Washington (each state’s firearm and motor vehicle mortality figures are listed below).

The decline of motor vehicle deaths results from decades of federal health-based injury prevention strategies that regulate vehicle safety standards and highway design.  Firearms, on the other hand, remain the only consumer product that is not federally regulated for health and safety, reports the VPC.

VPC’s Legislative Director Kristen Rand said:

    Americans are reaping the benefits of smart safety regulation of motor vehicles.  The idea that gun deaths exceed motor vehicle deaths in 10 states is stunning when one considers that 90 percent of American households own a car while fewer than a third own firearms.  It is also important to consider that motor vehicles--unlike guns--are essential to the functioning of the entire U.S. economy.  It is time to end firearms’ status as the last unregulated consumer product.]]></description>
<dc:subject>gun firearms death mortality health policy US risk regulation state list statistics data violence comparison geography demographics cars motor vehicles</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:1f1e32e38696/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:gun"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:firearms"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:death"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:mortality"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:health"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:policy"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:US"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:risk"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:regulation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:state"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:list"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:statistics"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:data"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:violence"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:comparison"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:geography"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:demographics"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cars"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:motor"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:vehicles"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.thedailybeast.com/articles/2011/01/11/20-deadliest-gun-states-from-mississippi-to-arizona.html">
    <title>20 Deadliest Gun States, From Mississippi to Arizona - The Daily Beast</title>
    <dc:date>2012-08-08T07:02:54+00:00</dc:date>
    <link>http://www.thedailybeast.com/articles/2011/01/11/20-deadliest-gun-states-from-mississippi-to-arizona.html</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>gun firearms death mortality regulation law crime US culture state list ownership statistics data violence</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:6819966a6ece/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:gun"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:firearms"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:death"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:mortality"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:regulation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:law"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:crime"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:US"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:culture"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:state"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:list"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:ownership"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:statistics"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:data"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:violence"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.sfgate.com/technology/dotcommentary/article/Web-Privacy-Census-shows-tracking-pervasive-3663642.php">
    <title>Web Privacy Census shows tracking pervasive - SFGate</title>
    <dc:date>2012-06-26T20:51:54+00:00</dc:date>
    <link>http://www.sfgate.com/technology/dotcommentary/article/Web-Privacy-Census-shows-tracking-pervasive-3663642.php</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[Privacy researchers have been calling for an ongoing tracking study since at least 1995, in part to gather a pool of data that can evaluate whether self-regulation really works. The strong sense is that when industry members agree to stop one practice, they simply start another.

In fact, this becomes apparent in the first Web Privacy Census report. Several years ago, a tracking tool known as a Flash cookie became a popular option for companies, because it could regenerate itself even after users had deliberately erased their cookies. In other words, they became popular because they allowed companies to continue monitoring consumers despite clearly stated preferences to the contrary.

After researchers caught companies red-handed using Flash cookies in this manner, several publicly agreed to stop. And indeed, the number of Flash cookies on the top 100 sites has dropped by 75 percent, based on the Web Privacy Census and an unrelated but comparable study in 2011.

But in that same time period, the use of what's known as HTML5 local storage, a technology with similar regenerative abilities, doubled. To be sure, HTML5 local storage isn't always deployed in this manner, but it potentially could be even more invasive, Hoofnagle said.

HTML5 is the emerging standard for Web development, so it will become increasingly difficult to block these tracking mechanisms without blocking content altogether.

As Hoofnagle said in a previous interview, the point was never that Flash was bad - the point was that persistent tracking is bad.

There have been a number of spot-check studies of online tracking in the past few years, and at least one multiyear survey. But it seems the Web Privacy Census is the first evaluation specifically set up to run in perpetuity.]]></description>
<dc:subject>privacy online Internet cookies technology tracking survey database law regulation earnest hatmandu David.E</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:bb938ed3ffcb/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:privacy"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:online"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Internet"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cookies"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:technology"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:tracking"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:survey"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:database"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:law"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:regulation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:earnest"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:hatmandu"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:David.E"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.scientificamerican.com/article.cfm?id=epa-atrazine-herbicide">
    <title>EPA Relies on Industry-Backed Studies to Assess Health Risks of Widely Used Herbicide: Scientific American</title>
    <dc:date>2012-06-16T06:59:25+00:00</dc:date>
    <link>http://www.scientificamerican.com/article.cfm?id=epa-atrazine-herbicide</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[EPA records obtained by The Huffington Post Investigative Fund show that at least half of the 6,611 studies the agency is reviewing to help make its decision were conducted by scientists and organizations with a financial stake in atrazine, including Syngenta or its affiliated companies and research contractors.

More than 80 percent of studies on which the EPA are relying have never been published. This means that they have not undergone rigorous "peer review" by independent scientists, a customary method to ensure studies are credible and scientifically sound before they can be published in major journals.

At the same time several prominent studies by independent academic scientists in well-respected scientific journals—showing negative reproductive effects of atrazine in animals and humans—are absent from the EPA's list.]]></description>
<dc:subject>herbicide poison environment environmental protection government regulation EPA agribusiness Switzerland risk benefit</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:17d12c5f66ed/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:herbicide"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:poison"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:environment"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:environmental"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:protection"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:government"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:regulation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:EPA"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:agribusiness"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Switzerland"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:risk"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:benefit"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.diabetesincontrol.com/index.php?option=com_content&amp;task=view&amp;id=12007&amp;Itemid=8">
    <title>Animas Corp [Johnson &amp; Johnson] Receives Warning Letter from the FDA</title>
    <dc:date>2012-02-12T22:11:50+00:00</dc:date>
    <link>http://www.diabetesincontrol.com/index.php?option=com_content&amp;task=view&amp;id=12007&amp;Itemid=8</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[Federal regulators have warned Johnson & Johnson that it could face fines and other sanctions for selling faulty insulin pumps and delaying disclosures of serious injuries to diabetics who were using its OneTouch Ping and 2020 pumps. The FDA ordered the Animas Corp. unit of J&J to explain why it kept selling pumps known to fail and also to submit a plan to rectify a failure to promptly report cases in which its device might have caused or contributed to death or serious injury....
In the issue with the Animas insulin pumps, some pump keypads for controlling how much insulin is injected were deteriorating prematurely, leading to failures. "We decided to go with a new keypad because it's more durable," [spokesperson Caoline] Pavis said.
But while Animas was lining up the new keypad supplier, it was still selling the older ones. The FDA demanded documents about the company's decision to do that.]]></description>
<dc:subject>corporatism capitalism mortality regulation medical devices insulin Johnson&amp;Johnson risk safety diabetes drug effects morbidity injury hospitalization ketoacidosis government accountability</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:e425bd3ef1c0/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:corporatism"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:capitalism"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:mortality"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:regulation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:medical"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:devices"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:insulin"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Johnson&amp;Johnson"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:risk"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:safety"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:drug"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:effects"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:morbidity"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:injury"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:hospitalization"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:ketoacidosis"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:government"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:accountability"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.cnet.com/8301-17918_1-57367751-85/hey-at-t-quit-whining/?tag=rtcol">
    <title>Hey, AT&amp;T, quit whining! | Dialed In - CNET Blogs</title>
    <dc:date>2012-01-29T21:36:32+00:00</dc:date>
    <link>http://www.cnet.com/8301-17918_1-57367751-85/hey-at-t-quit-whining/?tag=rtcol</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[Unlike most of the windbags currently roaming Capitol Hill, this was a case of the federal government doing its job. And it wasn't only the FCC, it was the Department of Justice and some well-reasoned state attorneys general.
This is what effective regulation of corporate greed is supposed to look like. Not all mergers are a good idea because you say that they are. This was one of them.
[CEO Stephenson invoked the ruling to justify raising prices....] Because AT&T can't get more spectrum, and because it pursued an ill-advised and destructive method for pursuing more spectrum, it has to raise your prices. Do you feel that on your face? That's AT&T spitting on it....Customers should not pay for your mistakes, AT&T, nor should they pay for ineffective politicians who care more about disagreeing than they do about getting something done....
[Stephenson implied] that the FCC's inaction on spectrum also means that AT&T won't be able to create jobs through capital investment projects...AT&T used a similar "It will create jobs!" line when promoting the merger.
How AT&T got some civil rights groups and labor unions to mouth that same promise will remain one of my life's deeper mysteries, especially since the consolidation of two major carriers (and two major GSM carriers) would likely have resulted in job losses through the elimination of redundancies.]]></description>
<dc:subject>labor employment jobs advocacy corruption lobbying corporatism capitalism regulation outbasket outbox</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:fb1f097b583d/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:labor"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:employment"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:jobs"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:advocacy"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:corruption"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:lobbying"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:corporatism"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:capitalism"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:regulation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:outbasket"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:outbox"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.diabetesincontrol.com/articles/53-diabetes-news/9249-iom-recommends-fda-set-new-standards-for-salt-in-foods">
    <title>IOM Recommends FDA Set New Standards for Salt in Foods</title>
    <dc:date>2012-01-14T19:11:49+00:00</dc:date>
    <link>http://www.diabetesincontrol.com/articles/53-diabetes-news/9249-iom-recommends-fda-set-new-standards-for-salt-in-foods</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[Asked to address the concerns of naysayers, who argue that there is little proof that reducing salt in the diet will have an effect on health outcomes and who say that the administration should not get involved in "nanny-state" activities like regulating the amount of sodium people consume, Bakris said that government-backed salt-reduction campaigns "have been very effective in the UK, in Finland (with a dramatic improvement in mortality) and in Japan, and there is absolutely no reason we should not do this.

"The reality is that there needs to be some guidance to the general public about this—most people do not read labels, most people don't pay attention, and they don't know how much salt is too much... Clearly, the FDA does have a role as a regulatory body to adjust sodium standards in foods so that they are in keeping with the current guidelines."

"It's certainly true that people who are in their 20's and teens don't need salt restriction for blood-pressure control, [but it is an acquired taste. If] you don't learn from a young age, it's going to catch up with you in your 40's, 50's, and 60's, when you actually will need some salt restriction..."

In response to what Bakris calls the "outcomes mafia, who say that unless we have an outcomes study it's impossible to make any conclusions," he remarked, "[C]ommon sense has to prevail. The FDA as a regulatory body has accepted the notion that lowering of blood pressure is a validated surrogate for a reduction in cardiovascular mortality and morbidity... To do an [outcomes] clinical trial...you would need well over 100 000 people, so it's not feasible. Let's be reasonable."

"If you are telling me that reducing BP by 5 to 7 mm Hg, which is what most of these salt restrictions will do, is not going to translate into a benefit, then I think we have to throw out all the clinical trials we have to date...[No meta-analysis of any clinical trials] fails to show that a reasonable reduction in blood pressure has not [sic] been associated with a benefit, certainly on stroke and to a lesser degree on coronary events...[T]he data are very consistent."

"I think the conflict of interest here needs to be established,...With all due respect, many of the people who are saying this are also consultants to the Salt Institute, they are lobbyists in their own right. They spin the data to make it suit what their needs are."

]]></description>
<dc:subject>health policy guidelines regulation salt sodium diet intake risk benefit medical research outcomes evidence surrogate indicator marker stroke cardiovascular blood circulation mortality morbidity corruption spin distortion food industry lobby earnest</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:4bb8acad927f/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:health"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:policy"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:guidelines"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:regulation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:salt"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:sodium"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diet"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:intake"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:risk"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:benefit"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:medical"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:outcomes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:evidence"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:surrogate"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:indicator"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:marker"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:stroke"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cardiovascular"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:blood"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:circulation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:mortality"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:morbidity"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:corruption"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:spin"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:distortion"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:food"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:industry"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:lobby"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:earnest"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.guardian.co.uk/commentisfree/2011/may/07/ben-goldacre-bad-science-new-drugs">
    <title>How flimsy research gets inferior drugs to market | Ben Goldacre | Comment is free | The Guardian</title>
    <dc:date>2012-01-13T05:28:38+00:00</dc:date>
    <link>http://www.guardian.co.uk/commentisfree/2011/may/07/ben-goldacre-bad-science-new-drugs</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[You might think drugs only get on the market if they've been shown to be useful. But "useful" can mean many different things: for FDA approval, for example, you only need trials to show your drug is better than a placebo. That's nice, but with most medical problems, we've already got some kind of treatment. We're not interested in whether your drug is better than nothing. We're interested in whether it's better than the best currently available option.

So it turns out that, out of all the 197 new drugs approved in the past decade, only 70% had data to show they were better than other treatments (and that's after you ignore drugs for conditions where there was no current treatment).

But the problems go beyond just using the wrong comparator: most of the trials we rely on to make real-world decisions also study drugs on highly unrepresentative, freakishly ideal patients. These patients are younger, with perfect single diagnoses, fewer other health problems, and so on.]]></description>
<dc:subject>medical academic peer-reviewed research corruption distortion Ben Goldacre science standards regulation enforcement ethics</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:6ec58afee8ac/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:medical"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:academic"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:peer-reviewed"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:corruption"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:distortion"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Ben"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Goldacre"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:science"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:standards"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:regulation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:enforcement"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:ethics"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.badscience.net/2010/07/i-love-research-about-research/#more-1738">
    <title>I love research about research – Bad Science</title>
    <dc:date>2012-01-13T05:19:51+00:00</dc:date>
    <link>http://www.badscience.net/2010/07/i-love-research-about-research/#more-1738</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[Isabelle Boutron and colleagues...took every trial published over one month that had a negative result – 72 in total – and then went through each trial report to look for evidence of “spin”: people trying to present the results in a positive light, or distract the reader from the fact that the trial was negative....
Sometimes the [original] researchers found some other positive result in the spreadsheets and pretended that this was what they intended to count as a positive result all along. Sometimes they reported a dodgy subgroup analysis. Sometimes they claimed to have found that their treatment was “non-inferior” to the comparison treatment (when in reality a “non-inferiority” trial requires a bigger sample of people, because you might have missed a true difference simply by chance). Sometimes they just brazenly banged on about how great the treatment was, despite the evidence.
There a lots of things in place to stop this kind of stuff from happening. Trials are supposed to be registered, before they begin, with their protocol described in full, so that highly motivated individuals can go back and check if researchers changed their minds about what constituted a positive result, retrospectively, after the results came in. There are also reporting guidelines, such as CONSORT, which formalise the information that is supposed to appear in any scientific paper resulting from a trial.
But there is no enforcement for any of this, everyone is free to ignore it, and commonly enough – as with newspapers, politicians, and quacks – uncomfortable facts are cheerfully spun away.]]></description>
<dc:subject>medical academic peer-reviewed research spin corruption distortion propaganda Ben Goldacre science standards regulation enforcement ethics writing</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:0ef7156f86b8/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:medical"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:academic"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:peer-reviewed"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:spin"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:corruption"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:distortion"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:propaganda"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Ben"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Goldacre"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:science"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:standards"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:regulation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:enforcement"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:ethics"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:writing"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.badscience.net/2009/12/by-me-in-the-bmj-the-dodginess-of-drug-company-trials/#more-1408">
    <title>By me in the BMJ: the dodginess of drug company trials – Bad Science</title>
    <dc:date>2012-01-13T05:12:43+00:00</dc:date>
    <link>http://www.badscience.net/2009/12/by-me-in-the-bmj-the-dodginess-of-drug-company-trials/#more-1408</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[The problems I have described are not new, and they have been described on many previous occasions. They could be fixed, without taking research out of the hands of industry altogether, but to do so would require that the drug companies recognised the scale of this scandal, and campaigned themselves for more effective regulation: demanding full mandatory publication of all trial data from themselves and their competitors, for example.
Instead we see inertia, and the failure of regulators to engage adequately with these serious problems. In medicine, bad information leads to bad decisions: we prescribe one drug where an alternative would have been more effective, or had fewer side effects; or we prescribe an expensive drug, unnecessarily, when a cheaper alternative was equally effective, and so we deprive the community of limited healthcare resources. This is dangerous and absurd. Doctors who are making treatment decisions need access to good quality trial data, presented transparently, and all of it, not just the positive findings that drug companies choose to share.]]></description>
<dc:subject>medical research pharmaceutical companies pharma big drug corruption secrecy conspiracy law crime regulation Ben Goldacre</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:845d35eeed45/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:medical"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:pharmaceutical"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:companies"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:big"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:drug"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:corruption"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:secrecy"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:conspiracy"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:law"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:crime"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:regulation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Ben"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Goldacre"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.badscience.net/2010/07/pharmaco-epidemiology-would-be-fascinating-enough-even-if-society-didnt-manage-it-really-really-badly/#more-1723">
    <title>Pharmaco-epidemiology would be fascinating enough even if society didn’t manage it really really badly – Bad Science</title>
    <dc:date>2012-01-13T05:05:42+00:00</dc:date>
    <link>http://www.badscience.net/2010/07/pharmaco-epidemiology-would-be-fascinating-enough-even-if-society-didnt-manage-it-really-really-badly/#more-1723</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[There is no excuse for companies witholding data from academics and doctors. But most revealing, as ever, are the deeprooted flaws this story exposes in our rather ad hoc systems for gathering, analysing, and disseminating evidence on risks and benefits of treatments.
This drug has been on the market since 1999, and it has seen billions of dollars of sales every year. There has been plenty of real patient experience of this treatment, but we have failed to capture it for analysis. Most of the trials included in these meta-analyses weren’t specifically designed to look at heart problems, and so the data on these, collected incidentally, is unpredictably inaccurate.
In an ideal world, for every patient, wherever possible, we could be gathering anonymised outcome data and comparing this against medication history, making exceptions only for those who put their anxieties about privacy above the lives of others (I will have this argument with you any time). In an ideal world, wherever a patient is given any treatment, and there is genuine uncertainty about which treatment is best, they would be simply and efficiently randomised to one treatment, and their progress monitored. In an ideal world, these notions would be so routinely embedded in our notion of what healthcare looks like that no patient would be bothered by it.
This isn’t fanciful, or difficult, or disproportionately expensive. Instead we have unsatisfactory hotchpotch of incomplete monitoring systems and unforgivable secrecy. ]]></description>
<dc:subject>medical research pharmaceutical companies pharma big drug corruption secrecy conspiracy law crime regulation Ben Goldacre</dc:subject>
<dc:source>https://pinboard.in/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:bc8dbbd3ab32/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:medical"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:pharmaceutical"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:companies"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:big"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:drug"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:corruption"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:secrecy"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:conspiracy"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:law"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:crime"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:regulation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Ben"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Goldacre"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.nytimes.com/2011/02/08/us/politics/08obama-text.html?pagewanted=all">
    <title>Obama’s Remarks at the Chamber of Commerce - NYTimes.com</title>
    <dc:date>2011-11-26T05:37:11+00:00</dc:date>
    <link>http://www.nytimes.com/2011/02/08/us/politics/08obama-text.html?pagewanted=all</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[Few of us would want to live in a society without rules that keep our air and water clean; that give consumers the confidence to [invest in financial markets or to buy groceries. When new standards are proposed, opponents often claim an assault on business and free enterprise. Drug companies argued the bill creating the FDA would "destroy the sale of patent remedies." Automakers predicted a seatbelt mandate would destroy the] industry....The President of the American Bar Association denounced child labor laws as "a communistic effort to nationalize children"....

Companies adapt and standards often spark competition and innovation...[Steve Chu, my Secretary of Energy, reminded me how the government set modest, gradual energy efficiency targets a couple decades ago. Companies competed to hit these markers, and] hit them every time, and then exceeded them. [A] typical fridge now costs half as much and uses a quarter of the energy...It saves families and businesses billions of dollars.]]></description>
<dc:subject>rhetoric US regulation efficiency compettiveness protection legislation safety standards editing samples Obama business capital capitalism corporatism energy economics social progress</dc:subject>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:3b6f31e55465/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:rhetoric"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:US"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:regulation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:efficiency"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:compettiveness"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:protection"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:legislation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:safety"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:standards"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:editing"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:samples"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:Obama"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:business"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:capital"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:capitalism"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:corporatism"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:energy"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:economics"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:social"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:progress"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.hpj.com/archives/2011/apr11/apr18/0401PreventFoodborneIllness.cfm?title=Health%20pros%20identify%20top%2010%20culprits%20in%20foodborne%20illnesses">
    <title>Health pros identify top 10 culprits in foodborne illnesses</title>
    <dc:date>2011-05-03T19:08:10+00:00</dc:date>
    <link>http://www.hpj.com/archives/2011/apr11/apr18/0401PreventFoodborneIllness.cfm?title=Health%20pros%20identify%20top%2010%20culprits%20in%20foodborne%20illnesses</link>
    <dc:creator>Michael.Massing</dc:creator><dc:subject>foo safety regulation government food-borne pathogens extension services state county</dc:subject>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:9e1c6a87910d/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:foo"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:safety"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:regulation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:government"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:food-borne"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:pathogens"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:extension"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:services"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:state"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:county"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://docs.google.com/viewer?a=v&amp;q=cache:uEsbgLFRoc8J:www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm071627.pdf+cardiovascular+treatment+type+2&amp;hl=en&amp;gl=us&amp;pid=bl&amp;srcid=ADGEESi3fTuyDxtLulfV739fcXV7-uTeJVUGenVFhIg5V-mbUx3uCYVFtTdgupdpJe4n3kT3mCpoTfIzZTgMQYvbJKhF5UyISC-QmK2yjHyrXqXJV9FpObKUjvROJRcnUeZo1-mgaxI4&amp;sig=AHIEtbT_0VRvaXr86ZmE0PXg8ihqP2Vo1g">
    <title>Guidance for Industry - Powered by Google Docs</title>
    <dc:date>2011-04-16T03:15:47+00:00</dc:date>
    <link>http://docs.google.com/viewer?a=v&amp;q=cache:uEsbgLFRoc8J:www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm071627.pdf+cardiovascular+treatment+type+2&amp;hl=en&amp;gl=us&amp;pid=bl&amp;srcid=ADGEESi3fTuyDxtLulfV739fcXV7-uTeJVUGenVFhIg5V-mbUx3uCYVFtTdgupdpJe4n3kT3mCpoTfIzZTgMQYvbJKhF5UyISC-QmK2yjHyrXqXJV9FpObKUjvROJRcnUeZo1-mgaxI4&amp;sig=AHIEtbT_0VRvaXr86ZmE0PXg8ihqP2Vo1g</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[The treatment goals for patients with diabetes have evolved significantly over the last 80 years, from preventing imminent mortality, to alleviating symptoms, to the now recognized objective of normalization or near normalization of glucose levels with the intent of forestalling diabetic complications....]]></description>
<dc:subject>remission normal treatment blood glucose sugar progression benefit risk cardiovascular medical research drug effects regulation via:FDA.gov references consensus mortality morbidity diabetes standards normoglycemia links what.I'm.reading prediabetes self care management T2D diagnosis</dc:subject>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:686b1cb28ca0/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:remission"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:normal"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:treatment"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:blood"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:glucose"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:sugar"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:progression"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:benefit"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:risk"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cardiovascular"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:medical"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:drug"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:effects"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:regulation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:via:FDA.gov"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:references"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:consensus"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:mortality"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:morbidity"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:standards"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:normoglycemia"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:links"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:what.I'm.reading"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:prediabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:self"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:care"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:management"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:T2D"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diagnosis"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://en.wikipedia.org/wiki/Bates_method#Margaret_Darst_Corbett">
    <title>Bates method - Wikipedia, the free encyclopedia</title>
    <dc:date>2011-02-08T20:46:51+00:00</dc:date>
    <link>http://en.wikipedia.org/wiki/Bates_method#Margaret_Darst_Corbett</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[Margaret Darst Corbett [teacher of the Bates method, stated,] "the optic nerve is really part of the brain, and vision is nine-tenths mental and one-tenth only physical." <br />
In [1940, Corbett was charged with violating] the Medical Practice Act of California for treating eyes without a licence. [M]any of her students testified on her behalf, describing...how she had enabled them to discard their glasses. One witness testified that he had been almost blind from cataracts, but that...his vision had improved to such an extent that for the first time he could read for 8 hours at a stretch without glasses. Corbett explained in court that she was practicing neither optometry nor ophthalmology and represented herself not as a doctor but only as an “instructor of eye training”.....<br />
The trial attracted widespread interest, as did the “not guilty” verdict. [The California State Legislature rejected a bill that would have] made such vision education illegal without an optometric or medical licence.]]></description>
<dc:subject>eyes vision improvement cited cognition perception brain science law courts legislation regulation self care</dc:subject>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:6bd25a73aadd/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:eyes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:vision"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:improvement"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cited"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cognition"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:perception"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:brain"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:science"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:law"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:courts"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:legislation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:regulation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:self"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:care"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.miller-mccune.com/politics/are-more-gun-laws-for-mentally-ill-off-target-26967/">
    <title>Are More Gun Laws for Mentally Ill Off Target? | Smart Journalism. Real Solutions. Miller-McCune.</title>
    <dc:date>2011-01-15T21:42:08+00:00</dc:date>
    <link>http://www.miller-mccune.com/politics/are-more-gun-laws-for-mentally-ill-off-target-26967/</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[Eliminating all violence by the mentally ill leaves 95-97% of the baseline level of violence intact. ]]></description>
<dc:subject>mental illness law crime guns violence risk benefit outbasket legislation regulation via:PLM outbox</dc:subject>
<dc:source>https://twitter.com/</dc:source>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:06bd5281fc67/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:mental"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:illness"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:law"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:crime"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:guns"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:violence"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:risk"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:benefit"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:outbasket"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:legislation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:regulation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:via:PLM"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:outbox"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.scienceline.org/2010/12/drugs-and-social-media-don%E2%80%99t-mix/">
    <title>Drugs and Social Media Don’t Mix » Scienceline</title>
    <dc:date>2010-12-10T02:20:06+00:00</dc:date>
    <link>http://www.scienceline.org/2010/12/drugs-and-social-media-don%E2%80%99t-mix/</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[Other drug companies, though...are undaunted by the FDA’s warnings and are continuing to use social media without even linking directly to adverse effect warnings,...Rather than having risks one click away, some ads require a click and then a scroll to the bottom of the page, where a viewer then has to follow another link to get the warnings. “Industry is probably trying to ride this wave” of unregulated social media...As services like Twitter and Facebook keep growing, companies feel increasingly compelled to use them to interact directly with consumers or to market their brands. 
“They’re falling all over themselves to get into the game. If you’re not in it, you can’t win it,” says Mack, who is also a blogger at Pharma Marketing Blog. But with looming FDA regulations, “that game will soon be over.”
]]></description>
<dc:subject>pharma marketing advertising capitalism ethics via:pfanderson regulation governmnet FDA health disparities</dc:subject>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:480e28741a24/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:pharma"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:marketing"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:advertising"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:capitalism"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:ethics"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:via:pfanderson"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:regulation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:governmnet"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:FDA"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:health"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:disparities"/>
</rdf:Bag></taxo:topics>
</item>
<item rdf:about="http://www.dlife.com/diabetes-news/2009/10/common_herbicides_and_fibrate.html">
    <title>Common Herbicides and Fibrate Drugs Block Nutrient-sensing &amp;#039;Taste&amp;#039; Receptor Found in Gut and Pancreas | Mosinger, B. Journal of Medicinal Chemistry online c. 2009-10</title>
    <dc:date>2009-11-08T07:15:11+00:00</dc:date>
    <link>http://www.dlife.com/diabetes-news/2009/10/common_herbicides_and_fibrate.html</link>
    <dc:creator>Michael.Massing</dc:creator><description><![CDATA[Certain common herbicides and lipid-lowering fibrate drugs act in humans to block T1R3, a nutrient-sensing taste receptor also present in intestine and pancreas.Commonly used in agriculture and medicine, these chemical compounds were not previously known to act on the T1R3 receptor. The T1R3 receptor is a critical component of both the sweet taste receptor and the umami (amino acid) taste receptor. First identified on the tongue, emerging evidence indicates that T1R3 and related taste receptors also are located on hormone-producing cells in the intestine and pancreas[; they] detect nutrients in the gut and trigger the release of hormones involved in the regulation of glucose homeostasis and energy metabolism. "Compounds that either activate or block T1R3 receptors could [potentially influence] diseases such as obesity, type II diabetes and metabolic syndrome," noted Monell geneticist and study leader Bedrich Mosinger, M.D., Ph.D.
]]></description>
<dc:subject>metabolism umami sweetness taste regulation pancreas gut digestion fibrate neuroendocrine herbicide environmental factor pollution obesity type 2 diabetes metabolic syndrome correlation mechanism peer-reviewed research etiology risk cause</dc:subject>
<dc:identifier>https://pinboard.in/u:Michael.Massing/b:ba4876ab6481/</dc:identifier>
<taxo:topics><rdf:Bag>	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:metabolism"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:umami"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:sweetness"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:taste"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:regulation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:pancreas"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:gut"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:digestion"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:fibrate"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:neuroendocrine"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:herbicide"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:environmental"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:factor"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:pollution"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:obesity"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:type"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:2"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:diabetes"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:metabolic"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:syndrome"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:correlation"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:mechanism"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:peer-reviewed"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:research"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:etiology"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:risk"/>
	<rdf:li rdf:resource="https://pinboard.in/u:Michael.Massing/t:cause"/>
</rdf:Bag></taxo:topics>
</item>
</rdf:RDF>